UBS Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18B Buy
5,981,411
+4,542,013
+316% +$876M 0.21% 107
2025
Q4
$265M Buy
1,439,398
+197,260
+16% +$34.6M 0.05% 440
2025
Q3
$191M Buy
1,242,138
+54,140
+5% +$8.19M 0.04% 616
2025
Q2
$166M Buy
1,187,998
+333,201
+39% +$46.7M 0.03% 630
2025
Q1
$126M Sell
854,797
-1,070,449
-56% -$155M 0.03% 777
2024
Q4
$252M Buy
1,925,246
+1,049,079
+120% +$147M 0.06% 407
2024
Q3
$137M Sell
876,167
-39,993
-4% -$6.46M 0.04% 579
2024
Q2
$143M Sell
916,160
-32,025
-3% -$4.82M 0.04% 474
2024
Q1
$128M Sell
948,185
-240,987
-20% -$31.9M 0.04% 533
2023
Q4
$160M Buy
1,189,172
+210,538
+22% +$27.4M 0.06% 387
2023
Q3
$133M Buy
978,634
+85,740
+10% +$11.7M 0.06% 399
2023
Q2
$128M Buy
892,894
+145,729
+20% +$21.4M 0.06% 407
2023
Q1
$104M Buy
747,165
+29,259
+4% +$3.94M 0.05% 446
2022
Q4
$97.3M Buy
717,906
+149,787
+26% +$18.8M 0.05% 501
2022
Q3
$62.3M Buy
568,119
+72,162
+15% +$9.15M 0.04% 597
2022
Q2
$65.5M Sell
495,957
-80,479
-14% -$10.6M 0.03% 600
2022
Q1
$76.5M Buy
576,436
+87,849
+18% +$10.5M 0.03% 625
2021
Q4
$56.9M Sell
488,587
-7,656
-2% -$901K 0.02% 884
2021
Q3
$59.6M Buy
496,243
+45,571
+10% +$5.3M 0.02% 776
2021
Q2
$54M Buy
450,672
+17,216
+4% +$1.89M 0.02% 812
2021
Q1
$43.1M Sell
433,456
-10,733
-2% -$1.08M 0.02% 938
2020
Q4
$44.4M Buy
444,189
+27,729
+7% +$2.94M 0.02% 850
2020
Q3
$45.6M Sell
416,460
-8,831
-2% -$982K 0.02% 692
2020
Q2
$45M Sell
425,291
-33,466
-7% -$3.46M 0.02% 656
2020
Q1
$41M Sell
458,757
-148,966
-25% -$14M 0.03% 633
2019
Q4
$60.6M Sell
607,723
-25,128
-4% -$2.37M 0.03% 660
2019
Q3
$56.4M Sell
632,851
-58,074
-8% -$5.04M 0.03% 625
2019
Q2
$57M Sell
690,925
-272,995
-28% -$21.4M 0.03% 612
2019
Q1
$77.9M Sell
963,920
-98,520
-9% -$7.77M 0.04% 456
2018
Q4
$80.7M Sell
1,062,440
-126,895
-11% -$9.91M 0.05% 435
2018
Q3
$94.1M Sell
1,189,335
-160,780
-12% -$12.2M 0.05% 426
2018
Q2
$94.8M Sell
1,350,115
-69,838
-5% -$5.02M 0.05% 415
2018
Q1
$99.3M Sell
1,419,953
-30,666
-2% -$2.12M 0.06% 386
2017
Q4
$101M Sell
1,450,619
-132,610
-8% -$8.94M 0.06% 410
2017
Q3
$107M Sell
1,583,229
-52,716
-3% -$3.33M 0.07% 359
2017
Q2
$112M Sell
1,635,945
-176,446
-10% -$11.5M 0.07% 341
2017
Q1
$113M Sell
1,812,391
-4,499
-0.2% -$262K 0.07% 308
2016
Q4
$99.3M Buy
1,816,890
+195,206
+12% +$11.1M 0.07% 338
2016
Q3
$107M Buy
1,621,684
+27,201
+2% +$1.78M 0.08% 300
2016
Q2
$96.3M Buy
1,594,483
+158,284
+11% +$9.19M 0.08% 316
2016
Q1
$80.9M Sell
1,436,199
-51,317
-3% -$3.08M 0.07% 329
2015
Q4
$101M Sell
1,487,516
-93,880
-6% -$6.16M 0.08% 298
2015
Q3
$101M Sell
1,581,396
-35,390
-2% -$2.33M 0.09% 277
2015
Q2
$103M Sell
1,616,786
-42,779
-3% -$2.93M 0.08% 302
2015
Q1
$114M Sell
1,659,565
-32,763
-2% -$2.28M 0.09% 277
2014
Q4
$119M Buy
+1,692,328
New +$121M 0.1% 256

Other funds holding AZN